ABOUT US
Company
Leadership
Board
Advisors
History
Investors
Join us
SCIENCE
LDHA
PIPELINE
NEWS
CONTACT US
中文
ABOUT US
Company
Leadership
Board
Advisors
History
Investors
Join us
SCIENCE
LDHA
PIPELINE
NEWS
CONTACT US
NEWS
META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15
The first candidate molecule derived from the innovative immunometabolism platform has completed preclinical development and is approaching the IND-enabling study stage.
Showcase
2025.10.15
All
Progress
Spotlight
Honor
Showcase
Care
Discovery Begins Asking How Life Works
ABOUT US
SCIENCE
LDHA
PIPELINE
NEWS
Copyright © 2026 Meta Pharmaceuticals Inc.
粤ICP备2026058060号